Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. DrugBank 薬物名(臨床試験情報から抽出) KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1 Desmopressin 5件: DDAVP; DESMOPRESSIN; Desmopressin Acetate; Desmopressine; Minirin1件: Desmopressin 💬2件: AVPR2,
F8 💬
4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬6件: 6, 64, 72, 75, 225, 288 💬
2 Empagliflozin 2件: Empagliflozin; Jardiance1件: Empagliflozin 💬1件: SLC5A2 💬-6件: 58, 65, 67, 72, 97, 257 💬
3 Exenatide 3件: Bydureon; Byetta; Exenatide1件: Exenatide 💬1件: GLP1R 💬3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬6件: 6, 17, 72, 78, 193, 233 💬
4 Melatonin 2件: Circadin; Melatonin1件: Melatonin 💬2件: MTNR1A,
MTNR1B 💬
2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬12件: 6, 8, 13, 37, 46, 49, 72, 78, 90, 97, 145, 202 💬
5 Oxytocin 2件: Oxytocin; Syntocinon1件: Oxytocin 💬1件: OXTR 💬4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬7件: 6, 72, 127, 168, 193, 206, 226 💬
6 Satavaptan 1件: Satavaptan---1件: 72 💬
7 Tolvaptan 3件: Jinarc; Samsca; Tolvaptan1件: Tolvaptan 💬1件: AVPR2 💬3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬4件: 67, 72, 86, 225 💬
8 Urea 1件: Urea2件: Urea ,
Urea C13 💬
--2件: 72, 251 💬